AUTL
Autolus Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$2.24
−2.18%Leverage
- Debt / equity
- 1.12x
- Net debt / equity
- -1.17x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -0.38x
- Net debt / EBITDA
- 0.40x
Liquidity & coverage
- Current ratio
- 4.89x
- Quick ratio
- 4.40x
- Cash ratio
- 2.93x
- Interest coverage
- -5.25x
- EBITDA / interest
- -4.70x
- Working capital
- $267.3M
Cash & dividend
- FCF / debt
- -2.84x
- Cash flow / debt
- -2.70x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026